April 10, 2018; 90 (15 Supplement) April 24, 2018
Effects of IONIS-HTTRx in Patients with Early Huntington’s Disease, Results of the First HTT-Lowering Drug Trial (CT.002)
Sarah Tabrizi, Blair Leavitt, Holly Kordasiewicz, Christian Czech, Eric Swayze, Daniel A. Norris, Tiffany Baumann, Irene Gerlach, Scott Schobel, Anne Smith, Roger Lane, C. Frank Bennett
First published April 9, 2018,
Sarah Tabrizi
1University College London London United Kingdom
Blair Leavitt
2University of British Columbia Vancouver BC Canada
Holly Kordasiewicz
3Ionis Pharmaceuticals Carlsbad CA United States
Christian Czech
4F. Hoffman-La Roche Ltd. Basel Switzerland
Eric Swayze
3Ionis Pharmaceuticals Carlsbad CA United States
Daniel A. Norris
3Ionis Pharmaceuticals Carlsbad CA United States
Tiffany Baumann
3Ionis Pharmaceuticals Carlsbad CA United States
Irene Gerlach
5F. Hoffmann-La Roche Ltd Basel Switzerland
Scott Schobel
6F. Hoffmann-La Roche Ltd. Basel Switzerland
Anne Smith
3Ionis Pharmaceuticals Carlsbad CA United States
Roger Lane
3Ionis Pharmaceuticals Carlsbad CA United States
C. Frank Bennett
3Ionis Pharmaceuticals Carlsbad CA United States
Effects of IONIS-HTTRx in Patients with Early Huntington’s Disease, Results of the First HTT-Lowering Drug Trial (CT.002)
Sarah Tabrizi, Blair Leavitt, Holly Kordasiewicz, Christian Czech, Eric Swayze, Daniel A. Norris, Tiffany Baumann, Irene Gerlach, Scott Schobel, Anne Smith, Roger Lane, C. Frank Bennett
Neurology Apr 2018, 90 (15 Supplement) CT.002;
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 90 no. 15 Supplement CT.002
Print ISSN:
Online ISSN:
History:
- First Published April 9, 2018.
Copyright & Usage:
© 2018
Author Disclosures
- Sarah Tabrizi1,
- Blair Leavitt2,
- Holly Kordasiewicz3,
- Christian Czech4,
- Eric Swayze3,
- Daniel A. Norris3,
- Tiffany Baumann3,
- Irene Gerlach5,
- Scott Schobel6,
- Anne Smith3,
- Roger Lane3 and
- C. Frank Bennett3
- Sarah Tabrizi1,
- Blair Leavitt2,
- Holly Kordasiewicz3,
- Christian Czech4,
- Eric Swayze3,
- Daniel A. Norris3,
- Tiffany Baumann3,
- Irene Gerlach5,
- Scott Schobel6,
- Anne Smith3,
- Roger Lane3 and
- C. Frank Bennett3
Article usage
Disputes & Debates: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Related Articles
- No related articles found.